RamsayPharma offers GxP consulting to the pharmaceutical industry worldwide
RamsayPharma Ltd. is an international Pharmaceutical Consultancy established by Ian Ramsay, a former MHRA GMP & GDP Inspector.
The company offers a range of bespoke services to the Pharmaceutical manufacturing industry. Support for simple and complex projects are available on a one-off or ongoing basis.
RamsayPharma can draw upon a range of industry experts, consultants and associates to meet your needs for more complex of resource intensive projects.
RamsayPharma offers support across a range of needs such as consulting, audits, remediation and training. We have extensive experience in supporting clients worldwide for a range of needs.
Regulatory Approvals Supported
Ian Ramsay, Owner & Director
Ian Ramsay is an ex-MHRA GMDP inspector who established RamsayPharma consulting in 2016 to support industry with quality and compliance needs.
Ian Ramsay has extensive experience in the Pharmaceutical Industry across a wide range of dose forms and processes.
A microbiologist with experience in Pharma and GMP/GDP Regulatory inspections, Ian can bring a wealth of knowledge to your organisation.
As an accredited LMLS (leading & managing lean sigma) Green Belt, Ian can bring a balanced and pragmatic approach to Quality and Compliance to your quality and compliance needs.
RamsayPharma have developed a range of e-learning modules to assist remote learning. Learn at your own pace and using any device.
Take a look at our offerings and enroll directly from the website
RamsayPharma have developed a range of digital products to help companies with common topics and challenges. SOPs, checklists, templates and more.
Check out our template and products for immediate purchase and download
News & Blogs
150+ companies rely on RamsayPharma to help them with their needs
Contact us today to see how we can help
RamsayPharma helped us prepare for EU Regulatory inspection and supported us through the process. We are now fully approved!
RamsayPharma helped us to respond to, remediate and move beyond a serious MHRA IAG referral. We are now fully compliant and out of IAG.
RamsayPharma helped us achieve US-FDA and EMA approval for our novel biosimilar facility. Swift, first-time approval of our new facility really made the difference!